Meeting
2013 ASCO Annual Meeting
Long-term symptom burden and orodental health of oropharyngeal cancer (OPC) survivors following treatment with chemoradiotherapy (CRT) or sequential therapy (ST).
Authors
Sewanti Atul Limaye
Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA
Sewanti Atul Limaye , Robert I. Haddad , Ann Partridge , Anne M. O'Neill , Andrea Radossi , Aditya V. Shreenivas , David Lorente , Glenn J. Hanna , Stephen T. Sonis , Lawrence N. Shulman , Marshall R. Posner , Jochen H. Lorch
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Survivorship
Citation
J Clin Oncol 31, 2013 (suppl; abstr 9530)
DOI
10.1200/jco.2013.31.15_suppl.9530
Abstract #
9530
Poster Bd #
19
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Randomized trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01): A Trans-Tasman Radiation Oncology Group study.
First Author: Danny Rischin
Poster
2016 Cancer Survivorship Symposium
Patient- versus physician-reported toxicities among survivors of head and neck cancer after chemoradiation: Prospective evaluation of screening methodologies.
First Author: Allen M. Chen
Poster
2023 ASCO Quality Care Symposium
Financial toxicity, quality of life, symptom burden, and access to resources in early-phase clinical trial (EP-CT) participants.
First Author: Sienna Durbin
Poster
2023 ASCO Annual Meeting
Profile of toxicities and quality of life in long-term survivors treated with immunotherapy: A prospective cross sectional trial.
First Author: Paolo Bossi